A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects

NCT03279146 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Tenofovir exalidex (TXL)

Sponsor

ContraVir Pharmaceuticals, Inc.